{"@id":"https://bioecon.ru/technology/cell-macroencapsulation-for-cns/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://en.bioecon.ru/technology/cell-macroencapsulation-for-cns/","json":"https://en.bioecon.ru/api/v1/technology/cell-macroencapsulation-for-cns/index.json"},"id":"cell-macroencapsulation-for-cns","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/integriculture/","https://bioecon.ru/companies/orf-genetics/","https://bioecon.ru/companies/simple-planet/","https://bioecon.ru/companies/cellmeat/","https://bioecon.ru/companies/aleph-farms/","https://bioecon.ru/companies/newlimit/","https://bioecon.ru/companies/cryoport-systems/","https://bioecon.ru/companies/becton-dickinson/","https://bioecon.ru/companies/eversyn-gmbh/"]},"maturity":7,"name":"Implantable Cell Macroencapsulation for CNS","regions":["ch","eu","us","cn"],"risk":"high","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Allogeneic cell line engineering"},{"n":2,"title":"Immunoprotective semi-permeable capsule"},{"n":3,"title":"Surgical stereotactic implantation"},{"n":4,"title":"Long-term factor secretion"}],"summary":"Implantable semi-permeable hollow-fiber macrocapsules loaded with genetically modified cells that continuously secrete neurotrophic factors directly into the cerebrospinal fluid, bypassing the BBB.","url":"/technology/cell-macroencapsulation-for-cns/","verified":"2026-11-22"}